West Nile virus (WNV) is a member of the family Flaviviridae and is a neurotropic pathogen responsible for severe human disease. Flavivirus-infected cells release virus particles that contain variable numbers of precursor membrane (prM) protein molecules at the viral surface. Consequently, antibodies are produced against the prM protein. These antibodies have been shown to activate the infectious potential of fully immature flavivirus particles in vitro. Here, we provide in vivo proof that prM antibodies render immature WNV infectious. Infection with antibody-opsonized immature WNV particles caused disease and death of mice, and infectious WNV was found in the brains and sera.West Nile virus (WNV) is a mosquito-borne flavivirus and an emerging pathogen responsible for encephalitis and neurological disease in humans (Mackenzie et al., 2004). Members of the family Flaviviridae, which also include dengue virus (DENV) and tick-borne encephalitis (TBEV) virus, are enveloped, ssRNA viruses and contain three structural proteins: capsid (C), envelope (E) and membrane (M). In mature virions, E is organized as 90 homodimers that lie flat against the viral surface forming a 'smooth' protein shell (Kuhn et al., 2002).Flaviviruses infect cells via receptor-mediated endocytosis, which is mediated by the E glycoprotein (Lindenbach, 2001;Mukhopadhyay et al., 2005;van der Schaar et al., 2007). Following RNA replication, immature virions are formed containing precursor membrane protein (prM) in a heterodimeric configuration with E extending from the viral surface as 60 trimeric spikes (Kuhn et al., 2002). These newly formed particles mature during virus egress through the secretory pathway, whereafter cleavage of prM by a furin-like protease generates infectious particles (Stadler et al., 1997). This cleavage is known to be fairly inefficient as the prM content of virus particles released from DENV-and WNV-infected cells is approximately 30 % (Moesker et al., 2010;Zybert et al., 2008). Furthermore, the prM content is variable on a per-particle basis, as recent studies have shown that both fully immature as well as partially immature, or nearly mature, particles exist in wild-type ( , 1997). Indeed, studies on TBEV, DENV and WNV have shown that cleavage of prM to M is required to activate the membrane-fusion machinery of the virus (Guirakhoo et al., 1991; Moesker et al., 2010;Stadler et al., 1997;Zybert et al., 2008). Interestingly, however, we recently observed that prM antibodies bind to fully immature DENV particles and facilitate cellular entry through Fc receptor and fusion in a furin-dependent manner (Rodenhuis-Zybert et al., 2010). Furthermore, antibodies against prM have been shown to enhance wt DENV infection (Huang et al., 2006) and the levels of prM antibodies were found to be higher in patients with secondary infections compared with sera from primary DENV infections (Lai et al., 2008). Moreover, a recent study showed that human anti-prM antibodies fail to efficiently neutralize immature DENV infection in primary m...